In the current study, we found that combinatorial therapy of PPP1R1A and IGF-1R inhibitors is superior to single treatment not only in limiting tumor growth but also lung metastasis (Figure 5) which has never been reported in prior studies. The gene discussed is IGF1R; the disease is neoplasm.